Chemoinformaics analysis of Methyl 3-hydroxydecanoate
| Molecular Weight | 202.294 | nRot | 8 |
| Heavy Atom Molecular Weight | 180.118 | nRig | 1 |
| Exact Molecular Weight | 202.157 | nRing | 0 |
| Solubility: LogS | -2.551 | nHRing | 0 |
| Solubility: LogP | 2.875 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 35.4454 |
| nHD | 1 | BPOL | 24.6746 |
| QED | 0.485 |
| Synth | 2.384 |
| Natural Product Likeliness | 1.123 |
| NR-PPAR-gamma | 0.121 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.043 |
| Pgp-sub | 0.552 |
| HIA | 0.007 |
| CACO-2 | -4.461 |
| MDCK | 0.0000374 |
| BBB | 0.99 |
| PPB | 0.66428 |
| VDSS | 0.791 |
| FU | 0.395161 |
| CYP1A2-inh | 0.488 |
| CYP1A2-sub | 0.647 |
| CYP2c19-inh | 0.326 |
| CYP2c19-sub | 0.799 |
| CYP2c9-inh | 0.156 |
| CYP2c9-sub | 0.648 |
| CYP2d6-inh | 0.006 |
| CYP2d6-sub | 0.109 |
| CYP3a4-inh | 0.039 |
| CYP3a4-sub | 0.188 |
| CL | 10.602 |
| T12 | 0.827 |
| hERG | 0.024 |
| Ames | 0.019 |
| ROA | 0.014 |
| SkinSen | 0.875 |
| Carcinogencity | 0.222 |
| EI | 0.966 |
| Respiratory | 0.13 |
| NR-Aromatase | 0.013 |
| Antiviral | No |
| Prediction | 0.548567 |